Medicare Expands GLP-1 Coverage to Weight Loss at $50 Copay, Anchoring a New Health-Economy Shift
TL;DR Summary
Medicare’s one-year Bridge Program now covers GLP-1 weight-loss medications (Foundayo, Wegovy, or Zepbound) for a $50 copay, extending access beyond diabetics to those with BMI 35+ or 27+ with conditions. The move could be a watershed for obesity treatment and trigger broader economic and policy shifts as demand and costs rise.
Topics:business#glp-1-drugs#health#health-policy#medicare-bridge-program#pharmaceutical-access#weight-loss
- Medicare is now offering $50 GLP-1 prescriptions. The US may never be the same. vox.com
- What older adults need to know before taking a GLP-1 medication to lose weight CNN
- What Older Adults Should Know About GLP-1 Drugs as Medicare Coverage Expands The New York Times
- Eligible seniors can get GLP-1s for $50 a month for weight loss alone ABC News - Breaking News, Latest News and Videos
- Healthy Returns: Walmart, CVS step in to help seniors navigate Medicare coverage of obesity drugs CNBC
Reading Insights
Total Reads
1
Unique Readers
13
Time Saved
2 min
vs 3 min read
Condensed
90%
529 → 51 words
Want the full story? Read the original article
Read on vox.com